Price Graph
Price
Yield
These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
|
(Mark One) |
|
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2017
OR
|
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to .
Commission File Number: 0-21810
GENTHERM INCORPORATED
(Exact name of registrant as specified in its charter)
|
|
Michigan |
|
95-4318554 |
|
|
|
(State or other jurisdiction of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
|
21680 Haggerty Road, Northville, MI |
|
48167 |
|
|
|
(Address of principal executive offices) |
|
(Zip Code) |
|
Registrant’s telephone number, including area code: (248) 504-0500
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
Large accelerated filer |
☒ |
|
Accelerated filer |
☐ |
|
Non-accelerated filer |
☐ |
(Do not check if a small reporting company) |
Smaller reporting company |
☐ |
|
Emerging growth company |
☐ |
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
At October 27, 2017, there were 36,680,528 issued and outstanding shares of Common Stock of the registrant.
|
Cover |
|||||
|
|
|
|
|||
|
|
|
3 |
|||
|
|
Item 1. |
|
|
|
3 |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
4 |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
6 |
|
|
|
|
Consolidated Condensed Statement of Changes in Shareholders’ Equity |
|
7 |
|
|
|
|
Notes to Unaudited Consolidated Condensed Financial Statements |
|
8 |
|
|
Item 2. |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
20 |
|
|
Item 3. |
|
|
|
25 |
|
|
Item 4. |
|
|
|
27 |
|
|
|
28 |
|||
|
|
Item 1. |
|
|
28 |
|
|
|
Item 1A. |
|
|
28 |
|
|
|
Item 2. |
|
|
28 |
|
|
|
Item 6. |
|
|
29 |
|
|
|
|
30 |
|||
2
CONSOLIDATED CONDENSED BALANCE SHEETS
(In thousands, except share data)
(Unaudited)
|
|
September 30,
|
|
|
December 31,
|
|
||
|
ASSETS |
|
|
|
|
|
|
|
|
Current Assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
$ |
147,626 |
|
|
$ |
177,187 |
|
|
Accounts receivable, less allowance of $1,082 and $1,391, respectively |
|
182,236 |
|
|
|
170,084 |
|
|
Inventory: |
|
|
|
|
|
|
|
|
Raw materials |
|
59,399 |
|
|
|
60,525 |
|
|
Work in process |
|
19,382 |
|
|
|
13,261 |
|
|
Finished goods |
|
34,604 |
|
|
|
31,288 |
|
|
Inventory, net |
|
113,385 |
|
|
|
105,074 |
|
|
Derivative financial instruments |
|
1,542 |
|
|
|
18 |
|
|
Prepaid expenses and other assets |
|
37,034 |
|
|
|
32,000 |
|
|
Total current assets |
|
481,823 |
|
|
|
484,363 |
|
|
Property and equipment, net |
|
190,825 |
|
|
|
172,052 |
|
|
Goodwill |
|
54,287 |
|
|
|
51,735 |
|
|
Other intangible assets, net |
|
52,520 |
|
|
|
57,557 |
|
|
Deferred financing costs |
|
1,008 |
|
|
|
1,221 |
|
|
Deferred income tax assets |
|
44,564 |
|
|
|
35,299 |
|
|
Other non-current assets |
|
37,561 |
|
|
|
40,803 |
|
|
Total assets |
$ |
862,588 |
|
|
$ |
843,030 |
|
|
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Current Liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
$ |
80,322 |
|
|
$ |
84,511 |
|
|
Accrued liabilities |
|
65,519 |
|
|
|
105,625 |
|
|
Current maturities of long-term debt |
|
3,445 |
|
|
|
2,092 |
|
|
Derivative financial instruments |
|
— |
|
|
|
1,395 |
|
|
Total current liabilities |
|
149,286 |
|
|
|
193,623 |
|
|
Pension benefit obligation |
|
8,170 |
|
|
|
7,419 |
|
|
Other liabilities |
|
5,207 |
|
|
|
4,092 |
|
|
Long-term debt, less current maturities |
|
142,446 |
|
|
|
169,433 |
|
|
Deferred income tax liabilities |
|
6,674 |
|
|
|
8,058 |
|
|
Total liabilities |
|
311,783 |
|
|
|
382,625 |
|
|
Shareholders’ equity: |
|
|
|
|
|
|
|
|
Common Stock: |
|
|
|
|
|
|
|
|
No par value; 55,000,000 shares authorized, 36,677,528 and 36,534,464 issued and outstanding at September 30, 2017 and December 31, 2016, respectively |
|
262,935 |
|
|
|
262,251 |
|
|
Paid-in capital |
|
14,206 |
|
|
|
10,323 |
|
|
Accumulated other comprehensive loss |
|
(25,223 |
) |
|
|
(69,091 |
) |
|
Accumulated earnings |
|
298,887 |
|
|
|
256,922 |
|
|
Total shareholders’ equity |
|
550,805 |
|
|
|
460,405 |
|
|
Total liabilities and shareholders’ equity |
$ |
862,588 |
|
|
$ |
843,030 |
|
See accompanying notes to the consolidated condensed financial statements.
3
CONSOLIDATED CONDENSED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
|
|
|
Three Months Ended
|
|
|
Nine Months Ended September 30, |
|
|
||||||||||
|
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
|
||||
|
Product revenues |
|
$ |
235,853 |
|
|
$ |
232,625 |
|
|
$ |
728,498 |
|
|
$ |
681,059 |
|
|
|
Cost of sales |
|
|
165,624 |
|
|
|
155,931 |
|
|
|
494,704 |
|
|
|
464,628 |
|
|
|
Gross margin |
|
|
70,229 |
|
|
|
76,694 |
|
|
|
233,794 |
|
|
|
216,431 |
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net research and development expenses |
|
|
19,721 |
|
|
|
19,745 |
|
|
|
60,633 |
|
|
|
54,552 |
|
|
|
Acquisition transaction expenses |
|
|
— |
|
|
|
22 |
|
|
|
— |
|
|
|
693 |
|
|
|
Selling, general and administrative expenses |
|
|
34,331 |
|
|
|
29,512 |
|
|
|
96,912 |
|
|
|
81,533 |
|
|
|
Total operating expenses |
|
|
54,052 |
|
|
|
49,279 |
|
|
|
157,545 |
|
|
|
136,778 |
|
|
|
Operating income |
|
|
16,177 |
|
|
|
27,415 |
|
|
|
76,249 |
|
|
|
79,653 |
|
|
|
Interest expense |
|
|
(1,250 |
) |
|
|
(660 |
) |
|
|
(3,633 |
) |
|
|
(2,287 |
) |
|
|
Foreign currency (loss) gain |
|
|
(7,340 |
) |
|
|
(873 |
) |
|
|
(21,920 |
) |
|
|
88 |
|
|
|
Other (expense) income |
|
|
(403 |
) |
|
|
359 |
|
|
|
6 |
|
|
|
754 |
|
|
|
Earnings before income tax |
|
|
7,184 |
|
|
|
26,241 |
|
|
|
50,702 |
|
|
|
78,208 |
|
|
|
Income tax expense |
|
|
630 |
|
|
|
6,018 |
|
|
|
10,233 |
|
|
|
27,646 |
|
|
|
Net income |
|
$ |
6,554 |
|
|
$ |
20,223 |
|
|
$ |
40,469 |
|
|
$ |
50,562 |
|
|
|
Basic earnings per share |
|
$ |
0.18 |
|
|
$ |
0.55 |
|
|
$ |
1.10 |
|
|
$ |
1.39 |
|
|
|
Diluted earnings per share |
|
$ |
0.18 |
|
|
$ |
0.55 |
|
|
$ |
1.10 |
|
|
$ |
1.38 |
|
|
|
Weighted average number of shares – basic |
|
|
36,742 |
|
|
|
36,477 |
|
|
|
36,713 |
|
|
|
36,426 |
|
|
|
Weighted average number of shares – diluted |
|
|
36,805 |
|
|
|
36,595 |
|
|
|
36,831 |
|
|
|
36,558 |
|
|
See accompanying notes to the consolidated condensed financial statements.
4
CONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
||||||||||
|
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
|
Net income |
|
$ |
6,554 |
|
|
$ |
20,223 |
|
|
$ |
40,469 |
|
|
$ |
50,562 |
|
|
Other comprehensive income (loss), gross of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments gain |
|
|
13,251 |
|
|
|
2,230 |
|
|
|
42,051 |
|
|
|
2,866 |
|
|
Unrealized (loss) gain on foreign currency derivative securities |
|
|
(1,234 |
) |
|
|
(868 |
) |
|
|
2,541 |
|
|
|
(624 |
) |
|
Unrealized gain on commodity derivative securities |
|
|
136 |
|
|
|
139 |
|
|
|
184 |
|
|
|
544 |
|
|
Other comprehensive income, gross of tax |
|
$ |
12,153 |
|
|
$ |
1,501 |
|
|
$ |
44,776 |
|
|
$ |
2,786 |
|
|
Other comprehensive income (loss), related tax effect: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments gain |
|
|
(49 |
) |
|
|
(13 |
) |
|
|
(158 |
) |
|
|
1,087 |
|
|
Unrealized (loss) gain on foreign currency derivative securities |
|
|
331 |
|
|
|
233 |
|
|
|
(683 |
) |
|
|
168 |
|
|
Unrealized gain on commodity derivative securities |
|
|
(50 |
) |
|
|
(51 |
) |
|
|
(67 |
) |
|
|
(201 |
) |
|
Other comprehensive income (loss), related tax effect |
|
$ |
232 |
|
|
$ |
169 |
|
|
$ |
(908 |
) |
|
$ |
1,054 |
|
|
Other comprehensive income, net of tax |
|
$ |
12,385 |
|
|
$ |
1,670 |
|
|
$ |
43,868 |
|
|
$ |
3,840 |
|
|
Comprehensive income |
|
$ |
18,939 |
|
|
$ |
21,893 |
|
|
$ |
84,337 |
|
|
$ |
54,402 |
|
See accompanying notes to the consolidated condensed financial statements.
5
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
|
|
Nine Months Ended September 30, |
|
|||||||
|
|
2017 |
|
|
2016 |
|
||||
|
Operating Activities: |
|
|
|
|
|
|
|
||
|
Net income |
$ |
40,469 |
|
|
$ |
50,562 |
|
||
|
Adjustments to reconcile net income to cash provided by operating activities: |
|
|
|
|
|
|
|
||
|
Depreciation and amortization |
|
32,663 |
|
|
|
27,724 |
|
||
|
Deferred income taxes |
|
(9,059 |
) |
|
|
(1,933 |
) |
||
|
Stock compensation |
|
8,559 |
|
|
|
6,856 |
|
||
|
Defined benefit plan expense |
|
96 |
|
|
|
151 |
|
||
|
Provision of doubtful accounts |
|
(353 |
) |
|
|
385 |
|
||
|
Loss on sale of property and equipment |
|
868 |
|
|
|
291 |
|
||
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
|
||
|
Accounts receivable |
|
(5,581 |
) |
|
|
(22,835 |
) |
||
|
Inventory |
|
(4,407 |
) |
|
|
(5,647 |
) |
||
|
Prepaid expenses and other assets |
|
(555 |
) |
|
|
2,826 |
|
||
|
Accounts payable |
|
(7,433 |
) |
|
|
6,508 |
|
||
|
Accrued liabilities |
|
(39,896 |
) |
|
|
6,123 |
|
||
|
Net cash provided by operating activities |
|
15,371 |
|
|
|
71,011 |
|
||
|
Investing Activities: |
|
|
|
|
|
|
|
||
|
Proceeds from the sale of property and equipment |
|
41 |
|
|
|
45 |
|
||
|
Acquisition of subsidiary, net of cash acquired |
|
(2,000 |
) |
|
|
(73,593 |
) |
||
|
Purchases of property and equipment |
|
(37,181 |
) |
|
|
(50,742 |
) |
||
|
Net cash used in investing activities |
|
(39,140 |
) |
|
|
(124,290 |
) |
||
|
Financing Activities: |
|
|
|
|
|
|
|
||
|
Borrowing of debt |
|
— |
|
|
|
75,000 |
|
||
|
Repayments of debt |
|
(25,906 |
) |
|
|
(32,368 |
) |
||
|
Excess tax expense from equity awards |
|
— |
|
|
|
(277 |
) |
||
|
Cash paid for financing costs |
|
— |
|
|
|
(650 |
) |
||
|
Cash paid for the cancellation of restricted stock |
|
(1,100 |
) |
|
|
(1,196 |
) |
||
|
Cash paid for the repurchase of common stock |
|
(5,326 |
) |
|
|
— |
|
||
|
Proceeds from the exercise of Common Stock options |
|
2,434 |
|
|
|
1,038 |
|
||
|
Net cash (used in) provided by financing activities |
|
(29,898 |
) |
|
|
41,547 |
|
||
|
Foreign currency effect |
|
24,106 |
|
|
|
66 |
|
||
|
Net decrease in cash and cash equivalents |
|
(29,561 |
) |
|
|
(11,666 |
) |
||
|
Cash and cash equivalents at beginning of period |
|
177,187 |
|
|
|
144,479 |
|
||
|
Cash and cash equivalents at end of period |
$ |
147,626 |
|
|
$ |
132,813 |
|
||
|
Supplemental disclosure of cash flow information: |
|
|
|
|
|
|
|
||
|
Cash paid for taxes |
$ |
67,160 |
|
|
$ |
18,183 |
|
||
|
Cash paid for interest |
$ |
3,171 |
|
|
$ |
1,963 |
|
||
|
Supplemental disclosure of non-cash transactions: |
|
|
|
|
|
|
|
||
|
Common Stock issued to Board of Directors and employees |
$ |
3,873 |
|
|
$ |
3,507 |
|
||
See accompanying notes to the consolidated condensed financial statements.
6
CONSOLIDATED CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY
(In thousands)
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
||
|
|
Common Stock |
|
|
Paid-in |
|
|
Comprehensive |
|
|
Accumulated |
|
|
|
|
|
||||||||
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
Income (Loss) |
|
|
Earnings |
|
|
Total |
|
||||||
|
Balance at December 31, 2016 |
|
36,534 |
|
|
$ |
262,251 |
|
|
$ |
10,323 |
|
|
$ |
(69,091 |
) |
|
$ |
256,922 |
|
|
$ |
460,405 |
|
|
Cumulative effect of accounting change due to adoption of ASU 2016-09 |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,496 |
|
|
|
1,496 |
|
|
Stock repurchase |
|
(164 |
) |
|
|
(5,326 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5,326 |
) |
|
Exercise of Common Stock options for cash |
|
187 |
|
|
|
3,237 |
|
|
|
(803 |
) |
|
|
— |
|
|
|
— |
|
|
|
2,434 |
|
|
Cancellation of restricted stock |
|
(32 |
) |
|
|
(1,100 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,100 |
) |
|
Stock option compensation |
|
— |
|
|
|
— |
|
|
|
4,686 |
|
|
|
— |
|
|
|
— |
|
|
|
4,686 |
|
|
Common Stock issued to Board of Directors and employees |
|
153 |
|
|
|
3,873 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,873 |
|
|
Currency translation, net |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
41,893 |
|
|
|
— |
|
|
|
41,893 |
|
|
Foreign currency hedge, net |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,858 |
|
|
|
— |
|
|
|
1,858 |
|
|
Commodity hedge, net |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
117 |
|
|
|
— |
|
|
|
117 |
|
|
Net income |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
40,469 |
|
|
|
40,469 |
|
|
Balance at September 30, 2017 |
|
36,678 |
|
|
$ |
262,935 |
|
|
$ |
14,206 |
|
|
$ |
(25,223 |
) |
|
$ |
298,887 |
|
|
$ |
550,805 |
|
See accompanying notes to the consolidated condensed financial statements.
7
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
Note 1 – The Company and Subsequent Events
Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies. Unless the context otherwise requires, the terms “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Our products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation, patient temperature management, environmental product testing and other consumer and industrial temperature control needs. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies and new applications from existing technologies to create product and market opportunities for a wide array of thermal management solutions.
North American Reorganization
On January 4, 2016 and January 5, 2016, the Company completed reorganization transactions (the “Reorganization”) related to our North American business operated from Windsor, Ontario, Canada (the “Windsor Operations”). As part of our original integration plan to eliminate redundancies associated with the 2011 acquisition of Gentherm GmbH (formerly named W.E.T. Automotive Systems AG), the Windsor Operations have been consolidated into our existing European and North American facilities. As a result of the Reorganization, some of the business activities previously performed by the Windsor Operations are now being performed by other subsidiaries.
Related to the Reorganization, the Company declared intercompany dividends, incurred and paid withholding taxes to the Canadian Revenue Agency of $7,600 during 2016. Additionally, the Company incurred income tax expense of $2,500 related to the intercompany dividends. These amounts incurred are expected to cover all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the potential future liquidation of the subsidiary.
In addition to the $7,600 of withholding tax and $2,500 of income taxes, the Reorganization required the Company to make a one-time income tax payment of approximately $32,600. The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 nor any subsequent quarter. The withholding tax payment was paid entirely in 2016. The income tax payments of $2,500 and $32,600 were paid during the first quarter of 2017.
Subsequent Events
We have evaluated subsequent events through the date that our consolidated condensed financial statements are issued. No events have taken place that meet the definition of a subsequent event requiring adjustments to or disclosures in this Form 10-Q.
Note 2 – Basis of Presentation and New Accounting Pronouncements
The accompanying unaudited consolidated condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in the audited annual consolidated financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been condensed or omitted pursuant to those rules and regulations. In the opinion of management, all adjustments, consisting of normal recurring items, considered necessary for a fair presentation of our results of operations, financial position and cash flows have been included. The balance sheet as of December 31, 2016 was derived from audited annual consolidated financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. Operating results for the three and nine months ended September 30, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. These consolidated condensed financial statements should be read in conjunction with the financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2016.
8
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
Note 2 – Basis of Presentation and New Accounting Pronouncements – Continued
Balance Sheet Reclassification
In June, 2017, the Company changed its classification of prepayments made during the construction of plant assets from prepaid expenses and other assets to other non-current assets on the consolidated condensed balance sheet. The Company reclassified $4,390 from prepaid expenses and other assets to other non-current assets on the December 31, 2016 consolidated condensed balance sheet in order to conform with the current year’s presentation.
Derivatives and Hedging
In August, 2017, the FASB issued ASU 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities.” ASU 2017-12 expands the number and type of nonfinancial and interest rate risk components an entity has the ability to designate as the hedged risk in a qualifying hedging relationship. ASU 2017-12 requires entities to present the earnings effect of the hedging instrument in the same income statement line item in which the earnings effect of the hedge item is reported. This approach simplifies the financial statement reporting for qualifying hedging relationships by eliminating the requirement to separately report the portion of the hedge deemed to be ineffective. For cash flow hedges, the entire change in the fair value of the hedging instrument included in the assessment of hedge effectiveness is recorded in other comprehensive income and reclassified to earnings when the hedged item affects earnings. Furthermore, income statement effects from fair value and cash flow hedges are to be presented in tabular disclosure.
ASU 2017-12 is effective for annual and any interim periods beginning after December 15, 2018. Early adoption of the amendments in this update are permitted. For cash flow hedges existing at the date of adoption, an entity should apply a cumulative catch-up adjustment related to eliminating the separate measurement of ineffectiveness to accumulative other comprehensive income with a corresponding adjustment to the opening balance of retained earnings as of the beginning of the fiscal year that an entity adopts the amendments in this update. We are currently in the process of determining the impact the implementation of ASU 2017-12 will have on the Company’s financial statements.
Share-Based Payment Awards
In May, 2017, the FASB issued ASU 2017-09, “Compensation – Stock Compensation (Topic 718): Scope of Modification Accounting.” ASU 2017-09 clarifies which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting, in accordance with Topic 718. An entity should account for the effect of a modification unless all of the following are met:
|
|
1. |
The fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified. If the modification does not affect any of the inputs of the valuation technique that the entity uses to value the award, the entity is not required to estimate the value immediately before and after the modification. |
|
|
2. |
The vesting conditions of the modified award are the same as the vesting conditions of the original award immediately before the original award is modified. |
|
|
3. |
The classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. |
ASU 2017-09 is effective for annual and any interim periods beginning after December 15, 2017. Early adoption of the amendments in this update is permitted. The amendments in ASU 2017-09 should be applied on a prospective basis and in the initial period of adoption, entities must disclose the nature of and reason for the change in accounting principle. The Company has not historically made changes to the terms or conditions of shared-based payment awards and does not expect adoption of ASU 2017-09 to have a material impact the consolidated financial statements when it is adopted in the first quarter of 2018.
9
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
Note 2 – Basis of Presentation and New Accounting Pronouncements – Continued
Goodwill Impairment
In January, 2017, the FASB issued ASU 2017-04, “Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.” ASU 2017-04 modified the concept of impairment of goodwill to be a condition that exists when the carrying value of a reporting unit that includes goodwill exceeds its fair value. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, limited to the total amount of goodwill allocated to that reporting unit. Entities no longer will determine goodwill impairment by calculating the implied fair value of goodwill by assigning the fair value of a reporting unit to all of its assets and liabilities as if the reporting unit had been acquired in a business combination.
ASU 2017-04 is effective for annual and any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. Early adoption of the amendments in this update is permitted. The amendments in ASU 2017-04 must be applied on a prospective basis and in the initial period of adoption, entities must disclose the nature of and reason for the change in accounting principle. The Company expects adoption of ASU 2017-04 will reduce the complexity of evaluating goodwill for impairment.
Business Combinations
In January, 2017, the FASB issued ASU 2017-01, “Business Combinations (Topic 805): Clarifying the Definition of a Business” to assist entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. To be considered a business, the integrated set of activities and assets to be evaluated must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create an output. If substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets, the integrated set or activities and assets is not considered a business. ASU 2017-01 provides a framework to assist entities in evaluating whether an integrated set of activities and assets include both an input and a substantive process when the assets’ fair value is not concentrated in a single identifiable asset or group of similar identifiable assets.
ASU 2017-01 is effective for fiscal years and interim periods beginning after December 15, 2017. The amendments in ASU 2017-01 should be applied on or after the effective date. No disclosure is required at adoption. The Company expects the impact from adopting this update to be immaterial to the consolidated financial statements.
Income Taxes
In October, 2016, the FASB issued ASU 2016-16, “Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory.” ASU 2016-16 modifies the current prohibition to recognize deferred income taxes from differences between the tax basis of assets in the buyer’s tax jurisdiction and their cost resulting from an intra-entity transfer from one tax-paying component to another tax-paying component of the same consolidated group. Under current GAAP, deferred income taxes for intra-entity asset transfers are not recognized until the asset is sold to an outside party. ASU 2016-16 allows entities to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs.
ASU 2016-16 is effective for fiscal years and interim periods beginning after December 15, 2017. For entities that issue interim financial statements and whose current fiscal year end date is December 31, 2016, early adoption was permitted during the three month period ending March 31, 2017. The amendments in ASU 2016-16 must be applied on a modified retrospective basis through a cumulate-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We did not early adopt ASU 2016-16 during the three month period ending March 31, 2017. The update will be adopted during the first quarter of 2018 and is expected to increase the Company’s 2018 effective tax rate by approximately 3% to 5%.
Leases
In February, 2016, the FASB issued ASU 2016-02, “Leases (Topic 842).” ASU 2016-02 requires lessees to recognize on their balance sheet a liability to make lease payments and a right-of-use asset representing its right to use the underlying asset for the lease term. Payments to be made in optional periods should be included in the measurement of lease assets and liabilities if the lessee is reasonably certain it will exercise an option to extend the lease or not exercise an option to terminate the lease. While ASU 2016-02 continues to differentiate between finance or capital leases and operating leases, the principal change from current lease accounting guidance is that lease assets and liabilities arising from operating leases will be recognized on the balance sheet.
10
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
Note 2 – Basis of Presentation and New Accounting Pronouncements – Continued
ASU 2016-02 is effective for fiscal years and interim periods beginning after December 15, 2018. Early adoption of the amendments in this update are permitted. Lessees are required to recognize and measure leases at the beginning of the earliest period presented using a modified retrospective approach which includes a number of practical expedients, including the ability to use hindsight in evaluating lessee options to extend or terminate a lease. An entity that elects to apply the practical expedients will be required to recognize a right-of-use asset and lease liability for all operating leases at each reporting date based on the present value of the remaining minimum rental payment that were tracked and disclosed under previous GAAP. We are currently in the process of determining the impact the implementation of ASU 2016-02 will have on the Company’s financial statements.
Statement of Cash Flows
In August, 2016, the FASB issued ASU 2016-15, “Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments.” ASU 2016-15 provides guidance on the classification of eight specific cash receipt and cash payment transactions in the statement of cash flows. The Company is currently evaluating the following transactions to determine the effect ASU 2016-15 will have on the Company’s consolidated statements of cash flows:
|
|
1) |
Debt extinguishment payments and debt prepayments are to be shown as cash outflows for financing activities. Presently, Gentherm classifies debt extinguishment payments within operating activities. |
|
|
2) |
Payments made to settle contingent consideration liabilities not made soon after the acquisition date of a business combination should be recognized as cash outflows for financing activities up to the amount of the liability recognized at the acquisition date. Payments, or the portion of a payment, to settle contingent consideration liabilities that exceed the amount of the liability recognized at the acquisition date will be recognized as cash outflows for operating activities. |
|
|
3) |
Cash receipts from the settlement of insurance claims, excluding those related to corporate-owned life insurance policies, shall be classified on the basis of the related insurance coverage. For example, proceeds received to cover claims issued under product recall liability insurance would be classified as cash inflows from operating activities. |
|
|
4) |
Cash receipts from the settlement of corporate-owned life insurance policies shall be classified as cash inflows from investing activities. |
The other cash receipt and cash payment transactions addressed by this update are not expected to impact the Company. For public companies , ASU 2016-15 is effective for fiscal years and interim periods beginning after December 15, 2017 and must be applied retrospectively to all periods presented. The Company will adopt the amendments in this update during the first quarter of 2018.
Revenue from Contracts with Customers
In May, 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers.” ASU 2014-09 was developed to enable financial statement users to better understand the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. This update’s core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Companies are to use a five-step contract review model to ensure revenue is recognized, measured and disclosed in accordance with this principle. The FASB has issued several amendments to the new standard, including a one-year deferral of the original effective date, and new methods for identifying performance obligations intended to reduce the cost and complexity of compliance.
This update permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the cumulative catch-up transition method). We have chosen to use the cumulative catch-up transition method. ASU 2014-09 will be effective for fiscal years and interim periods beginning after December 15, 2017. Early application is not permitted.
11
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
Gentherm is executing a plan to complete the five-step contract review process for all existing contracts with customers, across all business units. While we continue to assess all potential impacts from this update, we currently believe the most significant impact will be to our automotive business unit and relates to our accounting for options that give customers the right to purchase additional goods under long-term supply agreements in the future. Due to the complexity of certain of our automotive supply contracts, the actual revenue recognition treatment for customer purchase options will depend on contract-specific terms and could vary from other contracts that are similar in nature. Based on our progress executing the five-step contract review process, we believe the implementation of ASU 2014-09 and any corresponding amendments will have an immaterial impact on the financial results of the Company.
Note 3 – Earnings Per Share
Basic earnings per share are computed by dividing net income by the weighted average number of shares of stock outstanding during the period. The Company’s diluted earnings per share give effect to all potential Common Stock outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the diluted earnings per share, the treasury stock method is used in determining the number of shares assumed to be issued from the exercise of Common Stock equivalents.
The following summarizes the Common Stock included in the basic and diluted shares, as disclosed on the face of the consolidated condensed statements of income:
|
|
Three Months
|
|
|
Nine Months
|
|
||||||||||
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
|
Weighted average number of shares for calculation of basic EPS |
|
36,742,168 |
|
|
|
36,477,044 |
|
|
|
36,713,294 |
|
|
|
36,425,626 |
|
|
Stock options under equity incentive plans |
|
62,908 |
|
|
|
117,537 |
|
|
|
117,919 |
|
|
|
132,737 |
|
|
Weighted average number of shares for calculation of diluted EPS |
|
36,805,076 |
|
|
|
36,594,581 |
|
|
|
36,831,213 |
|
|
|
36,558,363 |
|
The accompanying table represents Common Stock issuable upon the exercise of certain stock options that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive.
|
|
Three Months
|
|
|
Nine Months
|
|
||||||||||
|
|
2017 |
|
|
2016 |
|
|
2017 |
|
|
2016 |
|
||||
|
Stock options outstanding for equity incentive plans |
|
1,845,784 |
|
|
|
1,455,534 |
|
|
|
1,845,784 |
|
|
|
1,455,534 |
|
Note 4 – Segment Reporting
Segment information is used by management for making strategic operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss.
The Company’s reportable segments are as follows:
|
|
● |
Automotive – this segment represents the design, development, manufacturing and sales of automotive seat comfort systems, specialized automotive cable systems and certain automotive and non-automotive thermal convenience products. |
|
|
• |
Industrial – the combined operating results of Gentherm Global Power Technologies (“GPT”), Cincinnati Sub-Zero Products, LLC (“CSZ”) and Gentherm’s advanced research and development division. Advanced research and development includes efforts focused on improving the efficiency of thermoelectric technologies and advanced heating wire technology as well as other applications. The segment includes government sponsored research projects. |
|
|
● |
Reconciling Items – include corporate selling, general and administrative costs and acquisition transaction costs. |
12
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
Note 4 – Segment Reporting – Continued
The tables below present segment information about the reported product revenues, depreciation and amortization and operating income (loss) of the Company for three and nine month periods ended September 30, 2017 and 2016. With the exception of goodwill, asset information by segment is not reported since the Company does not manage assets at a segment level. As of September 30, 2017, goodwill assigned to our Automotive and Industrial segments were $23,514 and $30,773, respectively. As of September 30, 2016, goodwill assigned to our Automotive and Industrial segments were $22,362 and $30,573, respectively.
|
Three Months Ended September 30, |
|
Automotive |
|
|
Industrial |
|
|
Reconciling
|
|
|
Consolidated
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2017: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product revenues |
|
$ |
215,175 |
|
|
$ |
20,678 |
|
|
$ |
— |
|
|
$ |
235,853 |
|
|
Depreciation and amortization |
|
|
9,423 |
|
|
|
1,334 |
|
|
|
715 |
|
|
|
11,472 |
|
|
Operating income (loss) |
|
|
37,179 |
|
|
|
(5,607 |
) |
|
|
(15,395 |
) |
|
|
16,177 |
|
|
2016: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product revenues |
|
$ |
212,369 |
|
|
$ |
20,256 |
|
|
$ |
— |
|
|
$ |
232,625 |
|
|
Depreciation and amortization |
|
|
8,631 |
|
|
|
989 |
|
|
|
557 |
|
|
|
10,177 |
|
|
Operating income (loss) |
|
|
54,408 |
|
|
|
(4,899 |
) |
|
|
(22,094 |
) |
|
|
27,415 |
|
|
Nine Months Ended September 30, |
|
Automotive |
|
|
Industrial |
|
|
Reconciling
|
|
|
Consolidated
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2017: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product revenues |
|
$ |
652,820 |
|
|
$ |
75,678 |
|
|
$ |
— |
|
|
$ |
728,498 |
|
|
Depreciation and amortization |
|
|
26,602 |
|
|
|
4,040 |
|
|
|
2,021 |
|
|
|
32,663 |
|
|
Operating income (loss) |
|
|
128,018 |
|
|
|
(10,741 |
) |
|
|
(41,028 |
) |
|
|
76,249 |
|
|
2016: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Product revenues |
|
$ |
634,636 |
|
|
$ |
46,423 |
|
|
$ |
— |
|
|
$ |
681,059 |
|
|
Depreciation and amortization |
|
|
23,566 |
|
|
|
2,578 |
|
|
|
1,580 |
|
|
|
27,724 |
|
|
Operating income (loss) |
|
|
133,271 |
|
|
|
(14,628) |
|
|
|
(38,990 |
) |
|
|
79,653 |
|
Total product revenues information by geographic area is as follows:
|
|
Three Months Ended September 30, |
|
|||||||||||||
|
|
2017 |
|
|
2016 |
|
||||||||||
|
United States |
$ |
104,033 |
|
|
|
44 |
% |
|
$ |
117,815 |
|
|
|
51 |
% |
|
China |
|
25,741 |
|
|
|
11 |
% |
|
|
21,573 |
|
|
|
9 |
% |
|
Germany |
|
17,711 |
|
|
|
8 |
% |
|
|
17,670 |
|
|
|
8 |
% |
|
South Korea |
|
16,569 |
|
|
|
7 |
% |
|
|
16,295 |
|
|
|
7 |
% |
|
Japan |
|
15,727 |
|
|
|
7 |
% |
|
|
10,532 |
|
|
|
4 |
% |
|
Canada |
|
10,667 |
|
|
|
5 |
% |
|
|
9,440 |
|
|
|
4 |
% |
|
Czech Republic |
|
9,175 |
|
|
|
4 |
% |
|
|
9,302 |
|
|
|
4 |
% |
|
United Kingdom |
|
8,143 |
|
|
|
3 |
% |
|
|
6,824 |
|
|
|
3 |
% |
|
Mexico |
|
5,706 |
|
|
|
2 |
% |
|
|
5,288 |
|
|
|
2 |
% |
|
Other |
|
22,381 |
|
|
|
9 |
% |
|
|
17,886 |
|
|
|
8 |
% |
|
Total Non U.S. |
|
131,820 |
|
|
|
56 |
% |
|
|
114,810 |
|
|
|
49 |
% |
|
|
$ |
235,853 |
|
|
|
100 |
% |
|
$ |
232,625 |
|
|
|
100 |
% |
13
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
|
|
Nine Months Ended September 30, |
|
|||||||||||||
|
|
2017 |
|
|
2016 |
|
||||||||||
|
United States |
$ |
337,697 |
|
|
|
46 |
% |
|
$ |
332,693 |
|
|
|
49 |
% |
|
China |
|
66,168 |
|
|
|
9 |
% |
|
|
57,983 |
|
|
|
9 |
% |
|
Germany |
|
53,273 |
|
|
|
7 |
% |
|
|
54,261 |
|
|
|
8 |
% |
|
South Korea |
|
50,714 |
|
|
|
7 |
% |
|
|
56,443 |
|
|
|
8 |
% |
|
Japan |
|
43,103 |
|
|
|
6 |
% |
|
|
32,545 |
|
|
|
5 |
% |
|
Canada |
|
32,709 |
|
|
|
5 |
% |
|
|
28,513 |
|
|
|
4 |
% |
|
Czech Republic |
|
29,826 |
|
|
|
4 |
% |
|
|
29,264 |
|
|
|
4 |
% |
|
United Kingdom |
|
26,250 |
|
|
|
4 |
% |
|
|
20,561 |
|
|
|
3 |
% |
|
Mexico |
|
16,398 |
|
|
|
2 |
% |
|
|
16,848 |
|
|
|
2 |
% |
|
Other |
|
72,360 |
|
|
|
10 |
% |
|
|
51,948 |
|
|
|
8 |
% |
|
Total Non U.S. |
|
390,801 |
|
|
|
54 |
% |
|
|
348,366 |
|
|
|
51 |
% |
|
|
$ |
728,498 |
|
|
|
100 |
% |
|
$ |
681,059 |
|
|
|
100 |
% |
Note 5 – Debt
Amended Credit Agreement
The Company, together with certain direct and indirect subsidiaries, have an outstanding Credit Agreement (the “Credit Agreement”) with a consortium of lenders and Bank of America, N.A., as administrative agent. The Credit Agreement was most recently amended on December 15, 2016 (the “Amended Credit Agreement”). As a result of such amendment, the aggregate principal amount available for borrowing under the secured revolving credit facility increased from $250,000 to $350,000.
All subsidiary borrowers and guarantors participating in the Amended Credit Agreement have entered into a related pledge and security agreement. The security agreement grants a security interest to the lenders in substantially all of the personal property of subsidiaries designated as borrowers to secure their respective obligations under the Amended Credit Agreement, including the stock and membership interests of specified subsidiaries (limited to 66% of the stock in the case of certain non-US subsidiaries). The Amended Credit Agreement restricts the amount of dividend payments the Company can make to shareholders. As of September 30, 2017, Gentherm had approximately $221 available to borrow under the U.S. Revolving Note, net of outstanding letters of credit totaling $330.
The Amended Credit Agreement requires the Company to maintain a minimum Consolidated Interest Coverage Ratio and Consolidated Leverage Ratio, each defined therein.
Under the Amended Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or Eurocurrency rate (“Eurocurrency Rate Loans”), plus a margin (“Applicable Rate”). The rate for Base Rate Loans is equal to the highest of the Federal Funds Rate (1.06% at September 30, 2017) plus 0.50%, Bank of America’s prime rate (4.25% at September 30, 2017), or a one month Eurocurrency rate (0.00% at September 30, 2017) plus 1.00%. The rate for Eurocurrency Rate Loans denominated in U.S. Dollars is equal to the London Interbank Offered Rate (1.23% at September 30, 2017). All loans denominated in a currency other than the U.S. Dollar must be Eurocurrency Rate Loans. Interest is payable at least quarterly.
The Applicable Rate varies based on the Consolidated Leverage Ratio reported by the Company. As long as the Company is not in default of the terms and conditions of the Amended Credit Agreement, the lowest and highest possible Applicable Rate is 1.25% and 2.00%, respectively, for Eurocurrency Rate Loans and 0.25% and 1.00%, respectively, for Base Rate Loans.
The Company also has two fixed interest rate loans with the German Investment Corporation (“DEG”), a subsidiary of KfW Banking Group, a Germany government-owned development bank:
14
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
DEG China Loan
The first DEG loan, a loan we used to fund capital investments in China (the “DEG China Loan”), is subject to semi-annual principal payments that began March, 2015 and end September, 2019. Under the terms of the DEG China Loan, the Company must maintain a minimum Debt-to-Equity Ratio, Current Ratio and Debt Service Coverage Ratio, as defined by the DEG China Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Automotive Systems (China) Ltd.
DEG Vietnam Loan
The Company’s second fixed interest rate loan agreement with DEG was used to finance the construction and set up of the Vietnam production facility (“DEG Vietnam Loan”). The DEG Vietnam Loan is subject to semi-annual principal payments beginning November, 2017 and ending May, 2023. Under the terms of the DEG Vietnam Loan, the Company must maintain a minimum Current Ratio, Equity Ratio and Enhanced Equity Ratio, as defined by the DEG Vietnam Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd.
The following table summarizes the Company’s debt at September 30, 2017 and at December 31, 2016.
|
|
September 30, 2017 |
|
|
December 31,
|
|
||||||
|
|
Interest
|
|
|
Principal
|
|
|
Principal
|
|
|||
|
Credit Agreement: |
|
|
|
|
|
|
|
|
|
|
|
|
Revolving Note (U.S. Dollar Denominations) |
|
2.99 |
% |
|
$ |
129,000 |
|
|
$ |
154,000 |
|
|
DEG China Loan |
|
4.25 |
% |
|
|
1,891 |
|
|
|
2,525 |
|
|
DEG Vietnam Loan |
|
5.21 |
% |
|
|
15,000 |
|
|
|
15,000 |
|
|
Total debt |
|
|
|
|
|
145,891 |
|
|
|
171,525 |
|
|
Current portion |
|
|
|
|
|
(3,445 |
) |
|
|
(2,092 |
) |
|
Long-term debt, less current maturities |
|
|
|
|
$ |
142,446 |
|
|
$ |
169,433 |
|
The scheduled principal maturities of our debt as of September 30, 2017 are as follows:
|
Year |
|
Revolving
|
|
|
DEG
|
|
|
DEG
|
|
|
Total |
|
||||
|
Remainder of 2017 |
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1,250 |
|
|
$ |
1,250 |
|
|
2018 |
|
|
— |
|
|
|
945 |
|
|
|
2,500 |
|
|
|
3,445 |
|
|
2019 |
|
|
— |
|
|
|
946 |
|
|
|
2,500 |
|
|
|
3,446 |
|
|
2020 |
|
|
— |
|
|
|
— |
|
|
|
2,500 |
|
|
|
2,500 |
|
|
2021 |
|
|
129,000 |
|
|
|
— |
|
|
|
2,500 |
|
|
|
131,500 |
|
|
2022 |
|
|
— |
|
|
|
— |
|
|
|
2,500 |
|
|
|
2,500 |
|
|
Thereafter |
|
|
— |
|
|
|
— |
|
|
|
1,250 |
|
|
|
1,250 |
|
|
Total |
|
$ |
129,000 |
|
|
$ |
1,891 |
|
|
$ |
15,000 |
|
|
$ |
145,891 |
|
Principal outstanding under the Revolving Note will be due and payable in full on March 17, 2021. As of September 30, 2017, we were in compliance, in all material respects, with all terms as outlined in the Amended Credit Agreement, DEG China Loan and DEG Vietnam Loan.
15
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in the location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.
The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $28,856 and $29,538 outstanding as of September 30, 2017 and December 31, 2016, respectively.
The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is one year. We had copper commodity swap contracts with a notional value of $1,617 and $407 outstanding at September 30, 2017 and December 31, 2016, respectively.
We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive income (loss) in the consolidated condensed balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive income (loss) is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.
The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term.
Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of September 30, 2017 is as follows:
|
|
|
|
|
|
|
Asset Derivatives |
|
Net Asset |
|
||||||
|
|
|
Hedge Designation |
|
Fair Value Hierarchy |
|
Balance Sheet Location |
|
|
Fair Value |
|
|
|
|||
|
Foreign currency derivatives |
|
Cash flow hedge |
|
Level 2 |
|
|
Current assets |
|
|
$ |
1,340 |
|
$ |
1,340 |
|
|
Commodity derivatives |
|
Cash flow hedge |
|
Level 2 |
|
|
Current assets |
|
|
$ |
202 |
|
$ |
202 |
|
16
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows:
|
|
|
Location |
|
Three Months Ended September 30, 2017 |
|
|
Three Months Ended September 30, 2016 |
|
|
Nine Months Ended September 30, 2017 |
|
|
Nine Months Ended September 30, 2016 |
|
||||
|
Foreign currency derivatives |
|
Product revenues |
|
$ |
54 |
|
|
$ |
— |
|
|
$ |
54 |
|
|
$ |
— |
|
|
|
|
Cost of sales |
|
1,424 |
|
|
(112 |
) |
|
1,303 |
|
|
23 |
|
||||
|
|
|
Selling, general and administrative |
|
— |
|
|
— |
|
|
|
(216 |
) |
|
139 |
|
|||
|
|
|
Other comprehensive income |
|
(1,234 |
) |
|
|
(868 |
) |
|
|
2,541 |
|
|
(624 |
) |
||
|
|
|
Foreign currency (loss) gain |
|
|
15 |
|
|
(41 |
) |
|
|
(62 |
) |
|
108 |
|
||
|
Total foreign currency derivatives |
|
|
|
$ |
259 |
|
|
$ |
(1,021 |
) |
|
$ |
3,620 |
|
|
$ |
(354 |
) |
|
Commodity derivatives |
|
Cost of sales |
|
$ |
(4 |
) |
|
$ |
(157 |
) |
|
$ |
25 |
|
|
$ |
(510 |
) |
|
|
|
Other comprehensive income |
|
136 |
|
|
139 |
|
|
184 |
|
|
544 |
|
||||
|
Total commodity derivatives |
|
|
|
$ |
132 |
|
|
$ |
(18 |
) |
|
$ |
209 |
|
|
$ |
34 |
|
We did not incur any hedge ineffectiveness during the three and nine months ended September 30, 2017 and 2016.
Note 7 – Fair Value Measurement
The Company bases fair value on a price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have adopted a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.
Level 2: Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability.
Level 3: Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.
In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value.
Except for derivative instruments (see Note 6), pension liabilities, pension plan assets and a corporate owned life insurance policy, the Company has no material financial assets and liabilities that are carried at fair value at September 30, 2017 and December 31, 2016. The carrying amounts of financial instruments comprising cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to the relatively short maturity of such instruments. The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs). The carrying values of the Company’s Amended Credit Agreement indebtedness for the periods ending September 30, 2017 and December 31, 2016, respectively, were not materially different than their estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 5). Discount rates used to measure the fair value of Gentherm’s DEG Vietnam Loan and DEG China Loan are based on quoted swap rates. As of September 30, 2017, the carrying values of the DEG Vietnam Loan and DEG China Loan were $15,000 and $1,891, respectively, as compared to an estimated fair value of $15,100 and $1,900, respectively. As of December 31, 2016, the carrying value of the DEG Vietnam Loan and DEG China Loan were $15,000 and $2,525, respectively, as compared to an estimated fair value of $14,900 and $2,600, respectively.
Certain Company assets are required to be recorded at fair value on a non-recurring basis when events and circumstances indicate that the carrying value may not be recoverable. As of September 30, 2017 and December 31, 2016, the Company did not realize any changes to the fair value of these assets due to the non-occurrence of events or circumstances that could negatively impact their recoverability.
17
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
Note 8 – Reclassifications Out of Accumulated Other Comprehensive Income (Loss)
Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the three months ended September 30, 2017 and September 30, 2016 are as follows:
|
|
|
Defined Benefit Pension Plans |
|
|
Foreign Currency Translation Adjustments |
|
|
Commodity Hedge Derivatives |
|
|
Foreign Currency Hedge Derivatives |
|
|
Total |
|
|||||
|
Balance at June 30, 2017 |
|
$ |
(2,550 |
) |
|
$ |
(37,071 |
) |
|
$ |
272 |
|
|
$ |
1,741 |
|
|
$ |
(37,608 |
) |
|
Other comprehensive income before reclassifications |
|
|
— |
|
|
|
13,251 |
|
|
|
153 |
|
|
|
106 |
|
|
|
13,510 |
|
|
Income tax effect of other comprehensive income before reclassifications |
|
|
— |
|
|
|
(49 |
) |
|
|
(56 |
) |
|
|
(29 |
) |
|
|
(134 |
) |
|
Amounts reclassified from accumulated other comprehensive income into net income |
|
|
— |
|
|
|
— |
|
|
|
(17 |
) |
a |
|
(1,340 |
) |
a |
|
(1,357 |
) |
|
Income taxes reclassified into net income |
|
|
— |
|
|
|
— |
|
|
|
6 |
|
|
|
360 |
|
|
|
366 |
|
|
Net current period other comprehensive income |
|
|
— |
|
|
|
13,202 |
|
|
|
86 |
|
|
|
(903 |
) |
|
|
12,385 |
|
|
Balance at September 30, 2017 |
|
$ |
(2,550 |
) |
|
$ |
(23,869 |
) |
|
$ |
358 |
|
|
$ |
838 |
|
|
$ |
(25,223 |
) |
|
(a) |
The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales. |
|
|
|
Defined Benefit Pension Plans |
|
|
Foreign Currency Translation Adjustments |
|
|
Commodity Hedge Derivatives |
|
|
Foreign Currency Hedge Derivatives |
|
|
Total |
|
|||||
|
Balance at June 30, 2016 |
|
$ |
(2,060 |
) |
|
$ |
(47,645 |
) |
|
$ |
26 |
|
|
$ |
179 |
|
|
$ |
(49,500 |
) |
|
Other comprehensive income (loss) before reclassifications |
|
|
— |
|
|
|
2,230 |
|
|
|
(8 |
) |
|
|
(818 |
) |
|
|
1,404 |
|
|
Income tax effect of other comprehensive income (loss) before reclassifications |
|
|
— |
|
|
|
(13 |
) |
|
|
3 |
|
|
|
220 |
|
|
|
210 |
|
|
Amounts reclassified from accumulated other comprehensive (income) loss into net income |
|
|
— |
|
|
|
— |
|
|
|
147 |
a |
|
|
(50 |
) |
a |
|
97 |
|
|
Income taxes reclassified into net income |
|
|
— |
|
|
|
— |
|
|
|
(54 |
) |
|
|
13 |
|
|
|
(41 |
) |
|
Net current period other comprehensive income |
|
|
— |
|
|
|
2,217 |
|
|
|
88 |
|
|
|
(635 |
) |
|
|
1,670 |
|
|
Balance at September 30, 2016 |
|
$ |
(2,060 |
) |
|
$ |
(45,428 |
) |
|
$ |
114 |
|
|
$ |
(456 |
) |
|
$ |
(47,830 |
) |
(a) The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.
18
GENTHERM INCORPORATED
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
(In thousands, except share and per share data)
(Unaudited)
Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the nine months ended September 30, 2017 and September 30, 2016 are as follows:
|
|
|
Defined Benefit Pension Plans |
|
|
Foreign Currency Translation Adjustments |
|
|
Commodity Hedge Derivatives |
|
|
Foreign Currency Hedge Derivatives |
|
|
Total |
|
|||||
|
Balance at December 31, 2016 |
|
$ |
(2,550 |
) |
|
$ |
(65,762 |
) |
|
$ |
241 |
|
|
$ |
(1,020 |
) |
|
$ |
(69,091 |
) |
|
Other comprehensive income before reclassifications |
|
|
— |
|
|
|
42,051 |
|
|
|
231 |
|
|
|
3,071 |
|
|
|
45,353 |
|
|
Income tax effect of other comprehensive income before reclassifications |
|
|
— |
|
|
|
(158 |
) |
|
|
(84 |
) |
|
|
(825 |
) |
|
|
(1,067 |
) |
|
Amounts reclassified from accumulated other comprehensive income into net income |
|
|
— |
|
|
|
— |
|
|
|
(47 |
) |
a |
|
(530 |
) |
a |
|
(577 |
) |
|
Income taxes reclassified into net income |
|
|
— |
|
|
|
— |
|
|
|
17 |
|
|
|
142 |
|
|
|
159 |
|
|
Net current period other comprehensive income |
|
|
— |
|
|
|
41,893 |
|
|
|
117 |
|
|
|
1,858 |
|
|
|
43,868 |
|
|
Balance at September 30, 2017 |
|
$ |
(2,550 |
) |
|
$ |
(23,869 |
) |
|
$ |
358 |
|
|
$ |
838 |
|
|
$ |
(25,223 |
) |
|
(a) |
The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales. |
|
|
|
Defined Benefit Pension Plans |
|
|
Foreign Currency Translation Adjustments |
|
|
Commodity Hedge Derivatives |
|
|
Foreign Currency Hedge Derivatives |
|
|
Total |
|
|||||
|
Balance at December 31, 2015 |
|
$ |
(2,060 |
) |
|
$ |
(49,381 |
) |
|
$ |
(229 |
) |
|
$ |
— |
|
|
$ |
(51,670 |
) |
|
Other comprehensive income (loss) before reclassifications |
|
|
— |
|
|
|
2,866 |
|
|
|
94 |
|
|
|
(117 |
) |
|
|
2,843 |
|
|
Income tax effect of other comprehensive income (loss) before reclassifications |
|
|
— |
|
|
|
1,087 |
|
|
|
(35 |
) |
|
|
32 |
|
|
|
1,084 |
|
|
Amounts reclassified from accumulated other comprehensive (income) loss into net income |
|
|
— |
|
|
|
— |
|
|
|
450 |
a |
|
|
(507 |
) |
a |
|
(57 |
) |
|
Income taxes reclassified into net income |
|
|
— |
|
|
|
— |
|
|
|
(166 |
) |
|
|
136 |
|
|
|
(30 |
) |
|
Net current period other comprehensive income |
|
|
— |
|
|
|
3,953 |
|
|
|
343 |
|
|
|
(456 |
) |
|
|
3,840 |
|
|
Balance at September 30, 2016 |
|
$ |
(2,060 |
) |
|
$ |
(45,428 |
) |
|
$ |
114 |
|
|
$ |
(456 |
) |
|
$ |
(47,830 |
) |
(a) The amounts reclassified from accumulated other comprehensive income (loss) are included in cost of sales.
We expect all of the existing gains and losses related to foreign currency derivatives reported in accumulated other comprehensive income as of September 30, 2017 to be reclassified into earnings during the next twelve months. We expect all of the existing gains and losses related to commodity derivatives reported in accumulated other comprehensive income as of September 30, 2017 to be reclassified into earning during the twelve month period ending December 31, 2017. See Note 6 for additional information about derivative financial instruments and the effects from reclassification to net income.
19
Forward-Looking Statements
This Report contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events, such as our ability to finance sufficient working capital, the amount of availability under our credit facility, our ability to continue to maintain or increase sales and profits of our operations, and the sufficiency of our cash balances and cash generated from operating, investing and financing activities for our future liquidity and capital resource needs. Reference is made in particular to forward-looking statements included in this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Such statements may be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “believe”, “estimate”, “anticipate”, “intend”, “continue”, or similar terms, variations of such terms or the negative of such terms. The forward-looking statements included in this Report are made as of the date hereof or as of the date specified and are based on management’s current expectations and beliefs. Such statements are subject to a number of assumptions, risks, uncertainties and other factors, which are set forth in “Item 1A. Risk Factors” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2016, and subsequent reports filed with or furnished to the Securities and Exchange Commission, and which could cause actual results to differ materially from that described in the forward-looking statements. Except as required by law, we expressly disclaim any obligation or undertaking to update any forward-looking statements to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
The following discussion and analysis should be read in conjunction with, and is qualified in its entirety by, our consolidated financial statements and related notes thereto included elsewhere in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2016.
Overview
Gentherm Incorporated is a global technology and industry leader in the design, development, and manufacturing of innovative thermal management technologies. Our products provide solutions for automotive passenger comfort and convenience, battery thermal management, remote power generation, patient temperature management, environmental product testing and other consumer and industrial temperature control needs. Our automotive products can be found on the vehicles of nearly all major automotive manufacturers operating in North America, Europe and Asia. We operate in locations aligned with our major customers’ product strategies in order to provide locally enhanced design, integration and production capabilities and to identify future thermal technology product opportunities in both automotive and other markets. We concentrate our research on the development of new technologies and new applications from existing technologies to create product and market opportunities for a wide array of thermal management solutions.
Our automotive products are sold to automobile and light truck OEMs or their tier one suppliers. Inherent to the automotive supplier market are costs and commitments that are incurred well in advance of the receipt of orders and resulting revenues from customers. This is due in part to automotive manufacturers requiring the design, coordination and testing of proposed new components and sub-systems. Revenues from these expenditures are typically not realized for two to three years due to this development cycle.
The Company has two reportable segments for financial reporting purposes: Automotive and Industrial. See Note 4 to our consolidated condensed financial statements for a description of our reportable segments as well as their proportional contribution to the Company’s reported product revenues and operating income. The financial information used by our chief operating decision maker to assess operating performance and allocate resources is based on these reportable segments.
North American Reorganization
On January 4, 2016 and January 5, 2016, the Company completed reorganization transactions (the “Reorganization”) related to our North American business operated from Windsor, Ontario, Canada (the “Windsor Operations”). As part of our original integration plan to eliminate redundancies associated with the 2011 acquisition of Gentherm GmbH (formerly named W.E.T. Automotive Systems AG), the Windsor Operations have been consolidated into our existing European and North American facilities. As a result of the Reorganization, some of the business activities previously performed by the Windsor Operations are now being performed by other subsidiaries.
Related to the Reorganization, the Company declared intercompany dividends, incurred and paid withholding taxes to the Canadian Revenue Agency of $7,600,000 during 2016. Additionally, the Company incurred income tax expense of $2,500,000 related to the intercompany dividends. These amounts incurred are expected to cover all future intercompany dividends needed to distribute the remaining earnings of the subsidiary to its parent in conjunction with the potential future liquidation of the subsidiary.
20
In addition to the $7,600,000 of withholding tax and $2,500,000 of income taxes, the Reorganization require d the Compan y to make a one-time income tax payment of approximately $32,600,000. The one-time income tax payment was accrued during the first quarter of 2016; however, the Company also recorded an offsetting deferred charge for approximately the same amount because the one-time income tax payment will result in tax deductions against income taxes in future periods. Therefore, the income tax payment did not have a material impact on the Company’s earnings during the first quarter of 2016 nor any subsequent quarter. Th e withholding tax payment was paid entirely in 2016. The income tax payments of $2,500,000 and $32,600,000 were paid during the first quarter of 2017.
Critical Accounting Policies
The discussion and analysis of our financial condition and results of operations are based upon our consolidated condensed financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. See Note 2 to our consolidated condensed financial statements for information about accounting standard updates adopted during the nine month period ended September 30, 2017 and their impact on the Company’s consolidated financial statements.
Results of Operations Third Quarter 2017 Compared with Third Quarter 2016
Product Revenues . Product revenues for the three months ended September 30, 2017 (“Third Quarter 2017”) were $235,853,000 compared with product revenues of $232,625,000 for the three months ended September 30, 2016 (“Third Quarter 2016”), an increase of $3,228,000, or 1.4%. Product revenues in the automotive segment increased by $2,806,000, or 1.3%, to $215,175,000. The industrial segment increased by $422,000, or 2.1%, to $20,678,000. The increase in the automotive segment occurred despite slowing automotive production volumes on a global basis and a special rebate of $2,000,000 recorded during Third Quarter 2017. Similar to the second quarter of 2017, o ur automotive OEM customers cut production on several vehicle programs during the period through one-time plant shut-downs intended to adjust vehicle inventories. These shut-downs impacted our Climate Controlled Seat (“CCS”) products disproportionately. CCS revenues were also reduced as a result of certain vehicle programs changing technologies from the higher priced active cooling seat application to heated and ventilated seat technology. Most of our other automotive products had higher revenue despite the weak production volumes. Steering Wheel Heaters were particularly strong growing $3,550,000, or 28%, to $16,439,000. Seat Heaters also increased by $3,287,000, or 4.4% to $77,793,000. Product revenues from GPT, included in the industrial segment, totaled $4,492,000 which represented a decrease of $620,000, or 12%. This decrease, which was even higher when compared to the GPT revenue totaling $7,501,000 during the 2017 second quarter, was mainly due to the deferral of a large customer project totaling $4,000,000 that will ship during the fourth quarter. Higher revenue for Cincinnati Sub-Zero Products, LLC (“CSZ”) totaling $16,186,000, representing an increase of $1,042,000, or 6.9%, offset the lower GPT revenue but was lower than the $20,065,000 in product revenue during the second quarter of 2017. This sequentially lower revenue totaling $3,879,000, or 19%, was partly due to $2,787,000 in lower environmental chamber revenue, and partly due to lower medical product sales of $1,092,000. The chamber sales were impacted by lower shipments of a large custom chamber while the lower medical product revenues were due to low sales of the blood heater cooler product that was higher during recent quarters due to product issues of a competitive product.
During the three months ended March 31, 2017, we revised our revenue by product analysis to better reflect pricing adjustments and other differences. We have revised prior year revenue by product amounts to reflect this change.
Cost of Sales. Cost of sales increased to $165,624,000 during Third Quarter 2017 from $155,931,000 during Third Quarter 2016. This increase of $9,693,000, or 6.2%, was due to unfavorable inventory adjustments, other increased expenses and changes in product mix. The gross margin percentage during Third Quarter 2017 decreased to 29.8% as compared to 33.0% during Third Quarter 2016 mainly as a result of these adjustments, expenses and mix issues and the special rebate. The unfavorable inventory adjustments totaled $2,307,000 and mainly were comprised of a reserve recorded for inventory held for the heated and cooled mattress product line based on a reduced sales outlook. Increased expenses included approximately $1,000,000 in overtime and other costs incurred at our Mexico factories, labor expense inflation at our Ukraine factory, and factory launch expenses for the new advanced battery thermal management product in our Macedonia facility. Other increased expenses include approximately $830,000 in cost overruns in CSZ’s industrial chamber business. Finally, we had an approximately $2,800,000 impact from an unfavorable shift in product mix where higher margin sales from GPT, CSZ’s medical products were lower during Third Quarter 2017 as compared to Third Quarter 2016.
Net Research and Development Expenses. Net research and development expenses were $19,721,000 during Third Quarter 2017 compared to $19,745,000 in Third Quarter 2016. An increase of $2,700,000 in gross expenses was offset by an equal amount of higher research and development reimbursements from both government and customer development programs. This increase in gross expenses was primarily driven by higher costs for additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. New product development includes automotive cooled storage devices, automotive interior thermal management devices, medical thermal management devices, battery thermal management devices, battery management systems, advanced automotive electronics solutions and other potential products.
21
Research and development reimbursement totaled $4,004,000 during Third Quarter 2017 an d $1,235,000 during Third Quarter 2016.
Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $34,331,000 during Third Quarter 2017, an increase of $4,819,000, or 16%, from $29,512,000 during Third Quarter 2016. This increase was partly due to expenses associated with the transition to a new chief executive officer, higher selling costs for CSZ’s medical products business and increased management incentive compensation costs. On June 28, 2017 we announced the upcoming retirement of Daniel R. Coker, our CEO, and related retirement package. During Third Quarter 2017 we recorded expenses totaling $2,537,000 which included accelerated stock compensation amortization and accrued cash bonus. The amount also includes a signing bonus for Mr. Coker’s successor and fees associated with the recruitment process. CSZ’s selling expenses, which started a program of hiring direct sales people for its medical division increased by $1,000,000 during Third Quarter 2017 as compared with Third Quarter 2016. Our management incentive program includes various forms of equity compensation including stock options, restricted stock and stock appreciation rights (“SARs”). Stock options and restricted stock are accounted for using the equity method and are valued at the grant date fair value and amortized over the respective service period of the employee beneficiary. SARs are accounted for using the liability method since they are settled in cash which requires mark-to-market adjustments based on the current trading price of Gentherm Common Stock. Since Gentherm Common Stock appreciated during the Third Quarter 2017, we recorded SAR related compensation expense totaling $112,000 for the period. This SAR related compensation expense was $350,000 higher as compared with a benefit during Third Quarter 2016 of $238,000. The benefit in 2016 was due to a decline in the Company’s trading price during that period. Other increases include business software implementation expenses associated with a new human resource management system and a new product lifecycle management application.
Foreign currency gain (loss). During Third Quarter 2017 we incurred a net foreign currency loss of $7,340,000 which included a net realized loss of $1,301,000 and a net unrealized loss of $6,039,000. The unrealized loss is primarily the result of holding significant amounts of U.S. Dollar (“USD”) cash at our subsidiaries in Europe which have the European Euro (“EUR”) as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies. During Third Quarter 2017, the USD weakened relative to the EUR. At June 30, 2017 the USD/EUR exchange rate was 1.14 whereas at September 30, 2017 the exchange rate was 1.18. If the USD continues to weaken we will likely have further unrealized currency losses whereas if the USD strengthens we will likely have unrealized gains. Third Quarter 2016, we had a foreign currency loss of $873,000. In comparison to 2017, the foreign currency impact in 2016 was less and mainly due to lower cash balances, less change in currency exchange rates and due to a higher ratio of cash held as Euro at our European subsidiaries.
Income Tax Expense. We recorded an income tax expense of $630,000 during Third Quarter 2017 representing an effective tax rate of 9% on earnings before income tax of $7,184,000. This amount included a $1,000,000 benefit to adjust an estimate of our research and development tax credit. Without the tax credit adjustment the effective tax rate for 2017 would have been 23%. During Third Quarter 2016, we recorded an income tax expense of $6,018,000 on earnings before tax of $26,241,000, or 23%. The effective tax rates for Third Quarter 2017 and Third Quarter 2016 were lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions and due to the tax credit adjustment during Third Quarter 2017.
Results of Operations Year to Date 2017 Compared with Year to Date 2016
Product Revenues . Our product revenues for the nine months ended September 30, 2017 (“YTD 2017”) were $728,498,000 compared with product revenues of $681,059,000 for the nine months ended September 30, 2016 (“YTD 2016”), an increase of $47,439,000, or 7.0%. This increase was partially attributable to the acquisition of CSZ, continued growth in our automotive product sales, and a partial recovery in product revenues from GPT. Revenues for CSZ during YTD 2017 were $56,273,000 and were $31,929,000 during YTD 2016. A portion of this increase is due to having operated as part of Gentherm for only six months during YTD 2016 since the acquisition was not closed until the April 1, 2016. This YTD product revenue for CSZ represented 18% growth for CSZ organically when considering that CSZ’s pro-forma product revenue during the three month period ended March 31, 2016, the comparable period prior to our acquisition, was $15,905,000. Despite slowing automotive production volumes on a global basis and a special rebate of $2,000,000 recorded during Third Quarter 2017 , our automotive product revenues increased by $18,184,000, or 3%, to $652,820,000 during YTD 2017. Our automotive OEM customers cut production on several vehicle programs during the period through one-time plant shut-downs intended to adjust vehicle inventories. These shut-downs impacted our CCS products disproportionately. CCS revenues were also reduced as a result of certain vehicle programs changing technologies from the higher priced active cooling seat application to heated and ventilated seat technology. Strong product revenue for Seat Heaters, which increased by $11,870,000, or 5.5%, during the YTD 2017 to $229,242,000 helped to offset the lower CCS revenues. This increase was driven partly by strong production volumes and new program launches and also reflects greater vehicle content due to an increasing number of vehicle programs offering seat heaters in rear set positions and higher system level content due to a greater number of programs having Gentherm electronics controllers. Revenue from Steering Wheel Heaters also increased by $8,982,000, or 24% to $45,983,000. This increase was due to new program launches and higher application rates on existing vehicles, and also
22
reflects a continued strong market trend whe re more vehicle models have added the feature. Product revenues from GPT totaled $19,4 05 ,000 which represented an increase of $4,91 1 ,000, or 3 4 %.
Cost of Sales. Cost of sales increased to $494,704,000 during YTD 2017 from $464,628,000 during YTD 2016. This increase of $30,076,000, or 6.5%, was due to the higher amount of product revenues and a one-time $3,973,000 expense recorded during YTD 2016 associated with the purchase accounting impact on inventory for the CSZ acquisition which occurred at the beginning of that period. The gross margin percentage during YTD 2017 was 32.1% as compared to 31.8% during YTD 2016, or 32.4% after adjusting for the one-time purchase accounting impact. The lower gross margin was due to unfavorable inventory adjustments, other increased expenses and changes in product mix during incurred mainly during the third quarter partially offset by higher CSZ and GPT product revenue, both of which have a higher than average gross margin percentage.
Net Research and Development Expenses. Net research and development expenses were $60,633,000 during YTD 2017 compared to $54,552,000 in YTD 2016, an increase of $6,081,000, or 11%. This increase was primarily driven by higher costs for additional resources, including personnel, focused on application engineering for new production programs of existing products, development of new products and a program to develop the next generation of seat comfort products. These increases were partially offset by research and development reimbursement totaling $7,835,000 during YTD 2017 and $4,450,000 during YTD 2016. The increase in reimbursements is primarily due to higher government programs.
We classify development and prototype costs and related reimbursements as net research and development expenses. This is consistent with accounting standards applied in the automotive industry. Depreciation costs for tooling are included in cost of sales.
Acquisition Transaction Expenses. During YTD 2016, we incurred $693,000 in fees and expenses associated with the acquisition of CSZ which was completed on April 1, 2016.
Selling, General and Administrative Expenses. Selling, general and administrative expenses increased to $96,912,000, an increase of $15,379,000, or 19%, from $81,533,000 during Third Quarter 2016. This increase was partly due to the acquisition of CSZ during YTD 2016, expenses associated with the transition to a new chief executive officer, higher selling costs for CSZ’s medical products business and increased management incentive compensation costs. Selling, general and administrative expenses included a full nine months of expenses for CSZ during YTD 2017, totaling $18,485,000, as compared to only six months during YTD 2016 which was $9,622,000 since the acquisition occurred on April 1, 2016. A portion of the increase was due to CSZ’s program of hiring direct sales people for its medical division, launched during the fourth quarter of 2016, which added $3,000,000 during YTD 2017. On June 28, 2017 we announced the upcoming retirement of Daniel R. Coker, our CEO, and related retirement package. During YTD 2017 we recorded expenses totaling $2,937,000 which included accelerated stock compensation amortization and accrued cash bonus. The amount also includes a signing bonus for Mr. Coker’s successor and fees associated with the recruitment process. Increased management incentive costs are primarily associated with adjustment to SAR’s associated with an increase in the trading price of Gentherm Common Stock during YTD 2016 as compared with a decrease in the trading price of Gentherm Common Stock during YTD 2016. During YTD 2017, we recorded SAR related compensation expense totaling $2,620,000 for the period. This SAR related compensation expense was $4,333,000 higher as compared with a benefit during YTD 2016 of $1,713,000. Other increases include business software implementation expenses associated with a new human resource management system and a new product lifecycle management application.
Foreign currency gain (loss). During YTD 2017 we incurred a net foreign currency loss of $21,920,000 which included a net realized loss of $2,495,000 and a net unrealized loss of $19,425,000. The unrealized loss is primarily the result of holding significant amounts of USD cash at our subsidiaries in Europe which have the EUR as the functional currency and due to certain intercompany relationships between these European subsidiaries and our U.S. based companies. During Third Quarter 2017, the USD weakened relative to the EUR. At December 31, 2016 the USD/EUR exchange rate was 1.05 whereas at September 30, 2017 the exchange rate was 1.18. If the USD continues to weaken we will likely have further unrealized currency losses whereas if the USD strengthens we will likely have unrealized gains. YTD 2016, we had a foreign currency gain of $88,000. In comparison to 2017, the foreign currency impact in 2016 was less and mainly due to lower cash balances, less change in currency exchange rates and due to a higher ratio of cash held as Euro at our European subsidiaries.
Income Tax Expense. We recorded an income tax expense of $10,233,000 during YTD 2017 representing an effective tax rate of 20% on earnings before income tax of $50,702,000. This amount included a $1,000,000 benefit to adjust an estimate of our research and development tax credit. Without the tax credit adjustment the effective tax rate for 2017 would have been 22%. During YTD 2016, we recorded an income tax expense of $27,646,000 which included the one-time withholding tax expense of $6,300,000 and other adjustments totaling $3,300,000 related to the Reorganization. Excluding this one-time expense and other adjustments, our income tax expense would have been $18,046,000 representing an effective tax rate of 23% on earnings before income tax of $78,208,000. The effective tax rates for YTD 2017, and YTD 2016, excluding the one-time expense related to the Reorganization, were lower than the U.S. Federal rate of 34% primarily due to the impact of lower statutory rates for our subsidiaries operating in foreign jurisdictions and due to the tax credit adjustment during YTD 2017 .
23
Liquidity and Capital Resources
The Company has funded its financial needs primarily through cash flows from operating activities and debt financings, as well as equity offerings on a supplemental basis. Based on its current operating plan, management believes cash and cash equivalents at September 30, 2017, together with cash flows from operating activities, along with borrowing available under our Amended Credit Agreement, are sufficient to meet operating and capital expenditure needs, and to service debt, for at least the next 12 months. However, if cash flows from operations decline, we may need to obtain alternative sources of capital and reduce or delay capital expenditures, acquisitions and investments, all of which could impede the implementation of our business strategy and adversely affect our results of operations and financial condition. In addition, it is likely that we will need to complete one or more equity or debt financings if we consummate any significant acquisition. There can be no assurance that such capital will be available at all or on reasonable terms, which could adversely affect our future operations and business strategy.
The following table represents changes in our cash and cash equivalents and short-term investments:
|
|
|
Nine Months Ended
|
|
|
Twelve Months Ended
|
|
||
|
|
|
2017 |
|
|
2016 |
|
||
|
|
|
(In Thousands) |
|
|||||
|
Cash and cash equivalents at beginning of period |
|
$ |
177,187 |
|
|
$ |
144,479 |
|
|
Cash provided by operating activities |
|
|
15,371 |
|
|
|
108,400 |
|
|
Cash used in investing activities |
|
|
(39,140 |
) |
|
|
(144,338 |
) |
|
Cash (used in) provided by financing activities |
|
|
(29,898 |
) |
|
|
79,858 |
|
|
Foreign currency effect on cash and cash equivalents |
|
|
24,106 |
|
|
|
(11,212 |
) |
|
Cash and cash equivalents at end of period |
|
$ |
147,626 |
|
|
$ |
177,187 |
|
We manage our cash, cash equivalents and short-term investments in order to fund operating requirements and preserve liquidity to take advantage of future business opportunities. Cash and cash equivalents decreased by $29,561,000 during YTD 2017. Cash provided by operating activities during YTD 2017 was $15,371,000, representing a decrease of $55,640,000 as compared to cash flow provided by operating activities during YTD 2016 which was $71,011,000. This decrease in cash provided by operating activities was driven by lower net income during YTD 2017 and the $2,500,000 and $32,600,000 income tax payments related to the Reorganization, plus non-cash expenses. Non-cash expenses included higher depreciation and amortization of $32,663,000, higher stock compensation of $8,559,000 and a net decrease in net operating assets and liabilities of $57,872,000 including working capital items. Higher depreciation and amortization in YTD 2017 resulted from purchases of property and equipment, driven largely by plant construction in Mexico, Vietnam, and Macedonia, and building improvements at CSZ. Our working capital increased during YTD 2017 due to sequentially higher product revenues and the settlement of accrued income tax liabilities related to the Reorganization.
As of September 30, 2017, working capital was $332,537,000 as compared to $290,740,000 at December 31, 2016, an increase of $41,797,000, or 14%. Despite a $29,561,000 decrease in cash and cash equivalents, working capital increased due to increases in accounts receivable, inventory and prepaid expenses and other assets, and decreases in accounts payable and accrued liabilities totaling $12,152,000, $8,311,000, $5,034,000, $4,189,000 and $40,106,000, respectively. Accounts receivable primarily increased as a result of increases in product revenues and timing differences between when sales in YTD 2017 were realized compared with sales realized in the fourth quarter of 2016. Accrued liabilities primarily decreased as a result of the income tax payments associated with the Reorganization totaling $35,100,000. Working capital was also affected by changes in currency exchange rates, which generally resulted in decreased working capital.
Cash used in investing activities was $39,140,000 during YTD 2017, reflecting purchases of property and equipment related to expansion of production capacity, including construction of new production facilities in Mexico and Macedonia, and replacement of existing equipment. A cash payment totaling $2,000,000 was made to the seller of CSZ to settle the tax gross-up included in the original purchase price.
Cash used in financing activities was $29,898,000 during YTD 2017, reflecting payments of principal on the U.S. Revolving Note and the DEG China Loan totaling $25,906,000 in aggregate. See Note 5 to our consolidated condensed financial statements for repayment terms and other information about each debt instrument. As of September 30, 2017, the total availability under the U.S. Revolving Note was $203,780,000.
24
Our exposure to market risk for changes in interest rates relates primarily to our debt obligations and foreign currency contracts. We have in the past, and may in the future, place our investments in bank certificates of deposits, debt instruments of the U.S. government, and in high-quality corporate issuers.
We are exposed to market risk from changes in foreign currency exchange rates, short-term interest rates and price fluctuations of certain material commodities such as copper. Market risks for changes in interest rates relate primarily to our debt obligations under our Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the European Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong.
The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which we hedge our exposure to foreign currency exchange risks is one year. We had foreign currency derivative contracts with a notional value of $28,856,000 and $29,538,000 outstanding at September 30, 2017 and December 31, 2016, respectively.
The maximum length of time over which we hedge our exposure to price fluctuations in material commodities is one year. We had copper commodity swap contracts with a notional value of $1,617,000 and $407,000 outstanding at September 30, 2017 and December 31, 2016, respectively.
We do not enter into derivative financial instruments for speculative or trading purposes. Our hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive income (loss) in the consolidated condensed balance sheet. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive income (loss) is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. We record the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. Though we continuously monitor the hedging program, derivative positions and hedging strategies, foreign currency forward exchange agreements have not always been designated as hedging instruments for accounting purposes.
The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the fair values of all derivative instruments in our consolidated condensed balance sheet as of September 30, 2017 is set forth in Note 6 to the consolidated condensed financial statements included herein.
Interest Rate Sensitivity
The table presents principal cash flows and related weighted average interest rates by expected maturity dates for each of the Company’s debt obligations. The information is presented in U.S. dollar equivalents, which is the Company’s reporting currency. The instruments actual cash flows are denominated in US dollars ($USD) or European Euros (€EUR), as indicated in parentheses.
September 30, 2017
|
|
|
Expected Maturity Date |
|
|||||||||||||||||||||||||||||
|
|
|
2017 |
|
|
2018 |
|
|
2019 |
|
|
2020 |
|
|
2021 |
|
|
Thereafter |
|
|
Total |
|
|
Fair
|
|
||||||||
|
|
|
(In thousands except rate information) |
|
|||||||||||||||||||||||||||||
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long Term Debt: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Rate (€EUR) |
|
|
— |
|
|
$ |
945 |
|
|
$ |
946 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
1,891 |
|
|
$ |
1,900 |
|
|
Fixed Interest Rate |
|
|
|
|
|
|
4.25 |
% |
|
|
4.25 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4.25 |
% |
|
|
|
|
|
Variable Rate ($USD) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
129,000 |
|
|
|
— |
|
|
$ |
129,000 |
|
|
$ |
129,000 |
|
|
Average Interest Rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.99 |
% |
|
|
|
|
|
|
2.99 |
% |
|
|
|
|
|
Fixed Rate ($USD) |
|
$ |
1,250 |
|
|
$ |
2,500 |
|
|
$ |
2,500 |
|
|
$ |
2,500 |
|
|
$ |
2,500 |
|
|
$ |
3,750 |
|
|
$ |
15,000 |
|
|
$ |
15,100 |
|
|
Fixed Interest Rate |
|
|
5.21 |
% |
|
|
5.21 |
% |
|
|
5.21 |
% |
|
|
5.21 |
% |
|
|
5.21 |
% |
|
|
5.21 |
% |
|
|
5.21 |
% |
|
|
|
|
25
The table below provides information about the Company’s foreign currency forward exchange rate agreements that are sensitive to changes in foreign currency exchange rates. The table presents the notional amounts and weighted average exchange rates by expected (contractual) maturity dates for each type of foreign currency forward exchange agreement. These notional amounts generally are used to calculate the contractual payments to be exchanged under the contract.
September 30, 2017
|
|
|
Expected Maturity or Transaction Date |
|
|||||||||||||||||||||||||||||
|
Anticipated Transactions And Related Derivatives |
|
2017 |
|
|
2018 |
|
|
2019 |
|
|
2020 |
|
|
2021 |
|
|
Thereafter |
|
|
Total |
|
|
Fair
|
|
||||||||
|
|
|
(In thousands except rate information) |
|
|||||||||||||||||||||||||||||
|
$US functional currency |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward Exchange Agreements: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Receive MXN/Pay USD$) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Contract Amount |
|
$ |
8,292 |
|
|
$ |
14,420 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
22,712 |
|
|
$ |
1,235 |
|
|
Average Contract Rate |
|
|
20.98 |
|
|
|
18.72 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19.55 |
|
|
|
|
|
|
(Receive USD$/Pay KRW) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Contract Amount |
|
$ |
6,143 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
6,143 |
|
|
$ |
105 |
|
|
Average Contract Rate |
|
|
1,123.19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,123.19 |
|
|
|
|
|
Commodity Price Sensitivity
The table below provides information about the Company’s futures contracts that are sensitive to changes in commodity prices, specifically copper prices. For the futures contracts the table presents the notional amounts in metric tons (MT), the weighted average contract prices, and the total dollar contract amount by expected maturity dates. Contract amounts are used to calculate the contractual payments and quantity of copper to be exchanged under the futures contracts.
September 30, 2017
|
|
|
Carrying
|
|
|
Fair
|
|
||
|
On Balance Sheet Commodity Position and Related Derivatives (in thousands) |
|
$ |
202 |
|
|
$ |
202 |
|
|
|
|
|
||||||
|
|
|
Expected Maturity |
||||||
|
|
|
2017 |
|
|
Fair
|
|
||
|
Related Derivatives |
|
|
|
|
|
|
|
|
|
Futures Contracts (Long): |
|
|
|
|
|
|
|
|
|
Contract Volumes (metric tons) |
|
|
280 |
|
|
|
|
|
|
Weighted Average Price (per metric ton) |
|
$ |
5,775 |
|
|
|
|
|
|
Contract Amount (in thousands) |
|
$ |
1,617 |
|
|
$ |
202 |
|
26
(a) Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this quarterly report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2017, our disclosure controls and procedures were effective to ensure the information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized, and reported within the time periods prescribed by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
(b) Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
27
We are subject to litigation from time to time in the ordinary course of business, however there is no current material pending litigation to which we are a party and no material legal proceeding was terminated, settled or otherwise resolved during the three or nine months ended September 30, 2017.
There were no material changes in our risk factors previously disclosed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2016. You should carefully consider the risks and uncertainties described therein.
Issuer Purchases of Equity Securities During Third Quarter 2017
|
Period |
|
|
Total Number of Shares Purchased* |
|
|
Average Price Paid per Share |
|
|
Total Number of Shares Repurchased as Part of Publicly Announced Plans or Programs |
|
|
Approximate Dollar Value of Shares That May Yet to Be Purchased Under the Plans or Programs |
||||||||
|
July 1, 2017 to July 31, 2017 |
|
|
|
|
80,000 |
|
|
|
$ |
34.09 |
|
|
|
|
80,000 |
|
|
|
$ |
97,220,300 |
|
August 1, 2017 to August 31, 2017 |
|
|
|
|
79,928 |
|
|
|
$ |
30.68 |
|
|
|
|
79,928 |
|
|
|
$ |
94,768,109 |
|
September 1, 2017 to September 30, 2017 |
|
|
|
|
3,000 |
|
|
|
$ |
31.35 |
|
|
|
|
3,000 |
|
|
|
$ |
94,674,059 |
|
* |
All shares were purchased on the open-market in accordance with Gentherm’s Stock Repurchase Program. The Stock Repurchase Program, authorized and announced on December 16, 2016, allows Gentherm to repurchase shares up to $100 million. The Stock Repurchase Program expires on December 16, 2019. The authorization of this stock repurchase program does not require that the Company repurchase any specific dollar value or number of share and may be modified, extended or terminated by the Company’s Board of Directors at any time. |
28
Exhibits to this Report are as follows:
|
|
|
|
|
|
|
Incorporated by Reference |
||||||
|
Exhibit
|
|
Exhibit Description |
|
Filed Herewith |
|
Form |
|
Period Ending |
|
Exhibit /
|
|
Filing Date |
|
10.1* |
|
Employment Contract between Gentherm Incorporated and Phillip Eyler dated as of September 18, 2017 |
|
|
|
8-K |
|
|
|
10.1 |
|
10/3/17 |
|
10.2.1* |
|
|
|
|
8-K |
|
|
|
10.1 |
|
8/3/15 |
|
|
10.2.2* |
|
Extension of Executive Relocation and Employment Agreement dated as of October 3, 2017 |
|
X |
|
|
|
|
|
|
|
|
|
31.1 |
|
|
X |
|
|
|
|
|
|
|
|
|
|
31.2 |
|
|
X |
|
|
|
|
|
|
|
|
|
|
32.1** |
|
|
X |
|
|
|
|
|
|
|
|
|
|
32.2** |
|
|
X |
|
|
|
|
|
|
|
|
|
|
101.INS |
|
XBRL Instance Document. |
|
X |
|
|
|
|
|
|
|
|
|
101.SCH |
|
XBRL Taxonomy Extension Schema Document. |
|
X |
|
|
|
|
|
|
|
|
|
101.CAL |
|
XBRL Taxonomy Extension Calculation Linkbase Document. |
|
X |
|
|
|
|
|
|
|
|
|
101.DEF |
|
XBRL Taxonomy Extension Definition Linkbase Document. |
|
X |
|
|
|
|
|
|
|
|
|
101.LAB |
|
XBRL Taxonomy Extension Label Linkbase Document. |
|
X |
|
|
|
|
|
|
|
|
|
101.PRE |
|
XBRL Taxonomy Extension Presentation Linkbase Document. |
|
X |
|
|
|
|
|
|
|
|
* Indicates management contract or compensatory plan or arrangement
** Documents are furnished not filed
29
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
Gentherm Incorporated |
|
|
|
/s/ D ANIEL R. C OKER |
|
Daniel R. Coker |
|
Chief Executive Officer |
|
(Duly Authorized Officer) |
|
|
|
Date: October 30, 2017 |
|
/s/ B ARRY G. S TEELE |
|
Barry G. Steele |
|
Chief Financial Officer |
|
(Principal Financial Officer and Principal Accounting Officer) |
|
|
|
Date: October 30, 2017 |
30
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Vulcan Materials Company | VMC |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|